Use of hematopoietic growth factors to control myelosuppression caused by radioimmunotherapy. [electronic resource]
- Cancer research Feb 1990
- 1003s-1007s p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0008-5472
Animals Antibodies, Monoclonal--toxicity Bone Marrow--drug effects Colony-Stimulating Factors--therapeutic use Cricetinae Female Granulocyte-Macrophage Colony-Stimulating Factor Growth Substances--therapeutic use Interleukin-1--therapeutic use Iodine Radioisotopes--toxicity Leukocyte Count Mesocricetus Neoplasms, Experimental--therapy Recombinant Proteins--therapeutic use